ARTICLE | Company News
Array, Amgen partner to develop autoimmune therapies against undisclosed target
July 28, 2017 4:26 PM UTC
Array BioPharma Inc. (NASDAQ:ARRY) and Amgen Inc. (NASDAQ:AMGN) partnered to discover and develop autoimmune disorder therapies against an undisclosed inflammation-related target. The target and undisclosed lead inhibitors were discovered by Array using its kinase-directed phenotypic screening platform. ...